Certain genetic variations in CYP1A1 and CYP3A4 genes were linked to hormone receptor-positive BC, indicating a potential role of these polymorphisms in hormone receptor expression and hormonal signaling pathways [220]. This evidence concerns the gene NR4A1 and breast cancer.